Key result
Very frequent depressive symptoms linked to ~38% higher incident CVD risk versus low frequency.
Why the study?
The study investigated the effects of gender and lifestyle on the association between the frequency of depressive symptoms and cardiovascular disease risk.
Does a higher frequency of depressive symptoms increase the risk of incident cardiovascular disease in middle-aged adults without prior CVD, and do gender and lifestyle modify this risk?
Cohort (n=502,505)
Yes
Does a higher frequency of depressive symptoms increase the risk of incident cardiovascular disease in middle-aged adults without prior CVD, and do gender and lifestyle modify this risk?
Effect estimate: HR 1.38 (95% CI 1.24-1.53)
p-value: p=< 0.001
A higher frequency of depressive symptoms is significantly associated with an increased risk of incident cardiovascular disease, particularly in women, but engaging in a healthier lifestyle can mitigate this risk.
Depressive symptom frequency was associated with higher CVD risk; leaves open whether screening or lifestyle interventions improve outcomes.
We investigated the effects of gender and lifestyle on the association between frequency of depressive symptoms and CVD risk. The UK Biobank is a national prospective cohort study that recruited 502,505 participants aged 40-69 years between 2006 and 2010. Participants without CVD were classified as having low, moderate, high, or very high frequency of depressive symptoms according to the number of days they felt depressed in a 2-week period. UKBB data include self-reported questionnaires covering lifestyle behaviors such as smoking, physical activity, eating habits, and sleep duration. The primary outcomes included incident CVD including coronary artery disease, ischemic stroke, hemorrhagic stroke, peripheral artery disease, atrial fibrillation/flutter, and heart failure. Cox proportional hazard models were used to evaluate the effects of gender and lifestyle on the association of frequency of depressive symptoms and CVD risk. During a median follow-up of 8.9 years, 27,394 (6.3%) developed CVD. The frequency of depressive symptoms increased the risk of CVD according to low, moderate, high, and very high frequency of depressive symptoms (P for trend < 0.001). The adjusted CVD risk was 1.38-fold higher for participants with very high frequency of depressive symptoms compared to those with low frequency of depressive symptoms (HR 1.38, 95% CI 1.24-1.53, P < 0.001). The correlation between frequency of depressive symptoms and CVD risk was more remarkable in females than in males. In participants with high or very high frequency of depressive symptoms, the individual lifestyle factors of no current smoking, non-obesity, non-abdominal obesity, regular physical activity, and appropriate sleep respectively was associated with lower CVD risk by 46% (HR 0.54, 95% CI 0.48-0.60, P < 0.001), 36% (HR 0.64, 95% CI 0.58-0.70, P < 0.001), 31% (HR 0.69, 95% CI 0.62-0.76, P < 0.001), 25% (HR 0.75, 95% CI 0.68-0.83, P < 0.001), and 22% (HR 0.78, 95% CI 0.71-0.86, P < 0.001). In this large prospective cohort study, a higher frequency of depressive symptoms at baseline was significantly associated with increased risk of CVD in the middle-aged population, and this relationship was prominent in women. In the middle-aged population with depressive symptoms, engaging in a healthier lifestyle could prevent CVD risk.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2023) conducted a cohort in Depressive symptoms (n=502,505). Very high frequency of depressive symptoms vs. Low frequency of depressive symptoms was evaluated on Incident cardiovascular disease including coronary artery disease, ischemic stroke, hemorrhagic stroke, peripheral artery disease, atrial fibrillation/flutter, and heart failure (HR 1.38, 95% CI 1.24-1.53, p=< 0.001). A very high frequency of depressive symptoms was associated with an increased risk of incident cardiovascular disease compared to a low frequency (HR 1.38; 95% CI 1.24-1.53; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: